n.a. (CXM)

0.65
0.01 1.52
OTC
Prev Close 0.66
Open 0.67
Day Low/High 0.61 / 0.67
52 Wk Low/High 0.50 / 3.48
Volume 52.56K
Exchange OTC
Div & Yield N.A. (N.A)

Latest News

Biotech 2013 by the Numbers: A Blockbuster Year

Biotech 2013 by the Numbers: A Blockbuster Year

The biotech sector closed 2013 up 65%, greatly outperforming the broader markets.

3 Biotech Stocks Under $10 Making Big Moves

3 Biotech Stocks Under $10 Making Big Moves

Keep these under-$10 biotech stocks on your radar.

Cardium To Present At The Rodman & Renshaw Annual 2012 Healthcare Investment Conference

Cardium To Present At The Rodman & Renshaw Annual 2012 Healthcare Investment Conference

Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J.

Biotech Stock Mailbag: Idenix vs. Pharmasset?

Biotech columnist Adam Feuerstein answers readers' questions and concerns about health care and drug-related stocks.

Biotech Stock Mailbag: Generex

Biotech columnist Adam Feuerstein answers readers' questions about drug and health care-related firms.

Telular, VirnetX: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.

Poniard's CEO Pulls a Belichick: BioBuzz

Risky late-game call puts Poniard in a deep financial hole.

A Closer Look at Cardium's Wound-Healing Drug: BioBuzz

Is it the drug or the gel that worked best in a phase II study?

Biotech Stock Mailbag: Cardium Therapeutics

The fall in Cardium shares might be related, at least partially, to what looks like so-so results from a phase IIb study announced on Oct. 14.

Cardium Therapeutics: Pump Up the Volume

Cardium Therapeutics fell sharply on heavy volume after it announced a $6 million registered direct offering.

Health Winners & Losers: Symmetry Medical

Symmetry Medical climbs on better-than-expected earnings.

Wednesday's Health Winners & Losers

Cardium Therapeutics climbs.